Polar Asset Management Partners’s Jasper Therapeutics JSPR Stock Holding History

Polar Asset Management Partners’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,374	Closed	-$1.93M	–	1315
2021 Q2	$1.93M	Hold	19,374	–	–	0.02%	570
2021 Q1	$1.92M	Sell	19,374 -626	-3%	-$63.7K	0.02%	506
2020 Q4	$2M	Sell	20,000 -27,500	-58%	-$2.74M	0.02%	345
2020 Q3	$4.71M	Hold	47,500	–	–	0.06%	226
2020 Q2	$4.87M	Buy	47,500 +15,000	+46%	+$1.47M	0.08%	230
2020 Q1	$3.09M	Buy	+32,500	New	+$3.18M	0.06%	231

Other funds holding JSPR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPARFS

Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Polar Asset Management Partners's JSPR Position: Q3 2021 in Review

Polar Asset Management Partners sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 19,374 shares — an estimated $1.93M sold.

Polar Asset Management Partners first reported a position in JSPR in Q1 2020 and held it in 6 quarters. The position peaked at $4.87M in Q2 2020. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.

Polar Asset Management Partners reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
Polar Asset Management Partners sold 19,374 Jasper Therapeutics shares in Q3 2021, an estimated $1.93M.
Polar Asset Management Partners first reported a position in Jasper Therapeutics in Q1 2020 and held it in 6 quarters.
Polar Asset Management Partners's Jasper Therapeutics position peaked at $4.87M in Q2 2020.
10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.